Skip to main content
Fig. 10 | BMC Cancer

Fig. 10

From: Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma

Fig. 10

Validation of prognostic efficiency of risk signature in TCGA-LIHC. A ROC analysis was employed to estimate the prediction value of the prognostic signature. B-D Areas under curves (AUCs) of the risk scores for predicting 1-, 2-, and 3-year overall survival time with other clinical characteristics. E Nomogram was assembled by stage and risk signature for predicting survival of HCC patients. F One-year nomogram calibration curves. G Two-year nomogram calibration curves. H Three-year nomogram calibration curves

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us